Address
Email address
Phone number
Website
OÜ KBM Pharma on ravimite turundusettevõte, mis tegeleb toidulisandite turunduse, ravimite hulgimüügi ning registreerimisega.
Name
osaühing KBM Pharma
Registry code
10251683
VAT number
EE100039557
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
20.08.1997 (27)
Financial year
01.01-31.12
Capital
6 350.00 €
Activity
68201 - Rental and operating of own or leased real estate 82991 - Other business support service activities n.e.c. 46461 - Wholesale of medicines and other pharmacy goods
4 265 554 €
565 892 €
13%
2 504 €
(estimate is approximate)
1 672 903 €
16
Submitted
No tax arrears
34%
22%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Uno Noole 07.02.1973 (51) | 12% - 762.00 EUR | - | - | |
Jaan Jänes 08.09.1973 (51) | 12% - 762.00 EUR | - | - | |
Andres Kaup 06.08.1968 (56) | 38% - 2 413.00 EUR | Board member | Direct ownership | |
Jaak Koppel 17.05.1966 (58) | 38% - 2 413.00 EUR | Board member | Direct ownership |
2019 06.10.2020 | 2020 22.06.2021 | 2021 25.04.2022 | 2022 20.06.2023 | 2023 25.03.2024 | |
---|---|---|---|---|---|
Total Revenue | 2 599 163 € | 2 678 485 € | 3 052 928 € | 3 889 672 € | 4 265 554 € |
Net profit (loss) for the period | 209 956 € | 333 696 € | 313 359 € | 719 747 € | 565 892 € |
Profit Margin | 8% | 12% | 10% | 19% | 13% |
Current Assets | 1 141 753 € | 1 364 981 € | 1 523 960 € | 2 271 450 € | 2 318 243 € |
Fixed Assets | 185 751 € | 170 875 € | 170 502 € | 256 923 € | 244 626 € |
Total Assets | 1 327 504 € | 1 535 856 € | 1 694 462 € | 2 528 373 € | 2 562 869 € |
Current Liabilities | 587 294 € | 611 950 € | 607 197 € | 921 362 € | 889 966 € |
Non Current Liabilities | 0 € | 0 € | 0 € | 0 € | 0 € |
Total Liabilities | - | - | - | - | - |
Share Capital | - | - | - | - | - |
Equity | 740 210 € | 923 906 € | 1 087 265 € | 1 607 011 € | 1 672 903 € |
Employees | 14 | 14 | 15 | 16 | 16 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 1 911 949.6 € | 173 444.17 € | 71 730.05 € | 13 |
2023 Q4 | 2 358 718.03 € | 162 784.98 € | 63 422.89 € | 14 |
2023 Q3 | 1 030 794.67 € | 190 481.25 € | 79 721.04 € | 14 |
2023 Q2 | 2 418 654.58 € | 140 813.01 € | 67 587.27 € | 15 |
2023 Q1 | 2 367 838.37 € | 188 919.06 € | 72 362.34 € | 15 |
2022 Q4 | 1 917 091.03 € | 145 817.05 € | 53 588.99 € | 15 |
2022 Q3 | 1 475 709.45 € | 122 862.77 € | 58 365.95 € | 14 |
2022 Q2 | 1 311 359.24 € | 133 720.85 € | 59 613.1 € | 13 |
2022 Q1 | 1 662 171.67 € | 140 540.18 € | 57 032.65 € | 13 |
2021 Q4 | 1 520 755.48 € | 140 599.35 € | 54 768.23 € | 14 |
2021 Q3 | 1 093 235.36 € | 99 718.63 € | 49 796.28 € | 13 |
2021 Q2 | 1 068 475.29 € | 109 347.74 € | 56 924.18 € | 13 |
2021 Q1 | 1 062 431.38 € | 102 955.04 € | 52 132.59 € | 15 |
2020 Q4 | 1 197 168.29 € | 104 219.76 € | 46 934.5 € | 15 |
2020 Q3 | 1 021 261.91 € | 102 287.83 € | 52 028.85 € | 14 |
2020 Q2 | 932 946.29 € | 100 726.87 € | 46 165.95 € | 14 |
2020 Q1 | 1 431 077.08 € | 112 127.19 € | 49 632.53 € | 14 |